Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
23,442,885
-
Shares change
-
-3,246,559
-
Total reported value, excl. options
-
$96,817,913
-
Value change
-
-$15,060,885
-
Put/Call ratio
-
117%
-
Number of buys
-
33
-
Number of sells
-
-63
-
Price
-
$4.13
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q2 2021
112 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q2 2021.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23,442,885 shares
of 55,482,166 outstanding shares and own 42.3% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6,391,176 shares), ARMISTICE CAPITAL, LLC (3,716,000 shares), VANGUARD GROUP INC (2,168,973 shares), CITADEL ADVISORS LLC (1,606,494 shares), BlackRock Inc. (942,666 shares), JPMORGAN CHASE & CO (919,826 shares), Erste Asset Management GmbH (742,900 shares), MORGAN STANLEY (734,350 shares), FEDERATED HERMES, INC. (678,325 shares), and ACADIAN ASSET MANAGEMENT LLC (666,854 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.